26. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001, 72:S1821-S1831.
27. American Heart Association. "Open-heart surgery statistics." 2007 http://americanheart.org/presenter.jhtml?identifier=4674
28. New York State Department of Health. "Adult cardiac surgery in New York State, 2002-2004. www.health. state.ny.us /diseases/ cardiovascular/ heart_disease /docs /cabg _2002-2004.pdf
29. Steiner, M. E., & Despotis, G. J. (2007). Transfusion algorithms and how they apply to blood conservation: The high-risk cardiac surgical patient. Hematol Oncol Clin North Am, 21(1), 177.
30. Society of Thoracic Surgeon Blood Conservation Guideline Task Force and Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. (2007). Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guidelines. Ann Thorac Surg, 2007; 83(5 Suppl), S27.
31. Hall, T. S., Brevetti, G. R., et al. Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes. Ann Thorac Cardiovasc Surg, 2001.7(6), 352.
32. Pass, S., & Simpson, R. "Discontinuation and reinstitution of medications during the perioperative period." Am J Health-Syst Pharm, 2004; 61(9), 899.
33. Vincentelli, A., Jude, B. et al. Antithrombotic therapy in cardiac surgery. Can J Anesth, 2006; 53(6), S89.
34. Harrington, R., Becker, R. et al. Antithrombotic therapy for coronary artery disease: The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004; 126, 513S.
35. 9Bhatt, D. L., Aranki, S., et al. Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization: A roundtable discussion. J Invasive Cardiol, 2005; 17(5), 283.
36. 10. Mannucci, P. M. & Levi, M. Prevention and treatment of major blood loss. N Engl J Med, 2007; 356 (22), 2301.
37. Food and Drug Administration. "FDA requests marketing suspension of Trasylol." 2007 www.fda.gov/bbs/topics/NEWS/2007/NEW01738.html
38. Arellano, R., Gan, B. S., et al. A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesth Analg, 2005, 100(6), 1846.
39. Food and Drug Administration. "FDA approves Voluven to treat serious blood volume loss following surgery." 2007. www.fda.gov/ bbs/topics/ NEWS/2007/ NEW0 1765.html Spiegelhalter D, Grigg O, Kinsman R. et al Risk‐adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery. Int J Qual Health Care 2003. 157–13.
40. Bucknell S J, Mohajeri M, Low J. et al Single‐versus multiple‐dose antibiotics prophylaxis for cardiac surgery. ANZ J Surg 2000. 70409–411.
41. Karthik S, Grayson A D, McCarron E E. et al Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004. 78527–534.
42. Dacey L J, Munoz J J, Baribeau Y R. et al Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Arch Surg 1998. 133442–447.
43. Bolsin S N, Colson M. Methodology matters; CUSUM. Int J Qual Health Care 2000. 12433–438.
44. Bolsin S. Routes to quality assurance: risk adjusted outcomes and personal professional monitoring. Int J Qual Health Care 2000. 12367–369.
45. Woodall W H. The use of control charts in health‐care and public‐health surveillance (with Discussion). J Qual Technol 2006. 3889–134.
46. Poloniecki J, Sismanidis C, Bland M. et al Retrospective cohort study of false alarm rates associated with a series of heart operations: the case for hospital mortality monitoring groups. BMJ 2004. 328375–379.]
47. Steiner S H, Cook R J, Farewell V T. et al Monitoring surgical performance using risk‐adjusted cumulative sum charts. Biostatistics 2000. 11441–1452.
48. Bird S M, Cox D, Farewell V T. et al Performance indicators: good, bad, and ugly. J R Stat Soc Ser A Stat Soc 2005. 1681–27.
49. Spiegelhalter D J, Aylin P, Best N G. et al Commissioned analysis of surgical performance using routine data: lessons from the Bristol inquiry. J R Stat Soc Ser A Stat Soc 2002. 165191–231.
50. Walshe K, Shortell S. When things go wrong: how health care organisations deal with major failures. Health Aff 2004. 23103–111.
51. Bolsin S, Colson M. Making the case for personal professional monitoring in health care. Int J Qual Health Care 2003. 151–2.
52. Bolsin S, Solly R, Patrick A. The value of personal professional monitoring performance data and open disclosure policies in anaesthetic practice: a case report. Qual Saf Health Care 2003. 12295–297.